drugset
drugset / Trial / NCT03385200

KVUS at Neoadjuvant CTx of Breast Cancer

NCT03385200 ↗

Phase 3 Unknown 60 enrolled RWTH Aachen University Univ.-Prof. Dr. med. F. Kiessling · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Effect of the contrast-enhanced diagnostic ultrasound during neoadjuvant chemotherapy of breast cancer on the achieved tumor size reduction and tolerability of chemotherapy

Timeline

Start
2016-12-12
Primary completion
2019-06-12
Completion
2019-12-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lumason Diagnostic / imaging agent — Intravenous

Indications

breast carcinoma